HRC calls on Turing CEO to lower price on HIV drug

WASHINGTON – Today, the Human Rights Campaign (HRC) once again called on Turing Pharmaceuticals CEO Martin Shkreli to make good on his unfulfilled promise of Sept. 22 to lower the price on Daraprim — a crucial and often lifesaving treatment for those living with HIV — and urged officials to expeditiously investigate Turing’s reckless overnight 5,000…

Read More

AHF: FDA commissioner nominee is ‘Too close for comfort’ to drug industry

LOS ANGELES — Friday AIDS Healthcare Foundation (AHF) President Michael Weinstein released the following statement on President Obama nominating cardiologist Dr. Robert M. Califf to head the U.S. Food and Drug Administration (FDA): “While Dr. Califf’s contributions to the research and clinical science community are well known and commendable, his cozy relationship with the pharmaceutical…

Read More

AHF: $750 drug that sells for $1 to government agencies underscores need for drug pricing reform

LOS ANGELES —AIDS Healthcare Foundation (AHF), the largest global AIDS organization that currently serves over 486,000 patients around the world each year, today denounced the lack of regulation and pharmaceutical industry greed that has led to record drug prices for specialty medications and billions of dollars in profits for drug manufacturers.  Most recently, Turing Pharmaceuticals…

Read More